BioSpace News Archive

InnerScope Hearing Technologies Inc. announced the launch of its HearingAssist brand FDA-Registered Over-the-Counter Rechargeable Hearing Aids including its EZHear Neckband Amplifier and other assorted HearingAssist branded hearing and hearing related supplies on Walgreens.com.

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces it has dosed the first patient in its human clinical study of a novel bladder MRI contrast agent.

Vuzix® Corporation, a leading supplier of Smart Glasses and Augmented Reality technology and products, announced that Proximie, a global health technology platform provider, has commenced rollout of PxLens following its initial introduction earlier this year.

Virpax® Pharmaceuticals, Inc., a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system disorders and viral barrier indications, announced recent progress made in its Envelta development program.

UroDev Medical, a medical device company working to improve the quality of life for people who suffer from neurogenic bladder and chronic urinary retention, has appointed medical device executive Dean Briesemeister as chief executive officer.

Although immunotherapies can successfully treat many types of cancer, they have shown limited effectiveness in advanced prostate cancer that has become resistant to treatment, known as metastatic castration-resistant prostate cancer (mCRPC).

Long COVID “brain fog” symptoms are linked to auditory processing disorder (APD), an underdiagnosed neurological disorder, suggests a new study from the Auditory Processing Institute of Queensland, Australia, published today in The Hearing Journal.

In a twist on the question, “Which came first, the chicken or the egg?”, scientists have long faced a similar question about how human adenovirus replicates.

Moss Genomics Inc. (CSE: MOSS) (“Moss” or the “Company”), a consumer genomics and gut microbiome company based in Vancouver, BC announces the introduction of its Cognitive Health Test

Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the 2022 Year End Financial Results on a Conference Call on April 10, 2023 at 8:30 am Eastern Time.